The quality of histopathology deliverables is among the most important responsibilities of a preclinical contract research organization (CRO). Results delivered on time and within budget but of a suboptimal quality will never meet the sponsor’s expectations and in reality, wastes valuable time and resources for all parties involved. Challenges can arise when there is a gap in necessary expertise, technology, or other infrastructure necessary to complete the study properly. Outlined below are a few specific areas where challenges frequently arise.